- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed and Refractory Multiple Myeloma
Total 61140 results
-
Millennium Pharmaceuticals, Inc.Completed
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Institute of Hematology & Blood Diseases HospitalBejing Institute for Stem Cell and Regenerative Medicine; Institute for Stem...RecruitingRefractory Leukemia | Relapsed Leukemia | Acute Myeloid Leukemia, ChildhoodChina
-
Celyad Oncology SAUnknownAcute Myeloid Leukemia/Myelodysplastic Syndrome | Multiple Myeloma (MM)United States, Belgium
-
University Health Network, TorontoAbbVie; CelgeneTerminatedAcute Myeloid Leukemia | Relapsed Cancer | Refractory Cancer | IDH2 Gene MutationCanada
-
The First Affiliated Hospital of Xiamen UniversityFujian Cancer Hospital; Dongguan People's Hospital; Huizhou Municipal Central... and other collaboratorsRecruitingLeukemia, Myeloid, Acute | Refractory Leukemia | Relapsed Adult AMLChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia | Refractory Leukemia | Immunotherapy | Relapsed Adult AMLChina
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingRelapsed/Refractory Acute Myeloid Leukemia (R/R AML)China
-
German Cancer Research CenterUniversity Hospital Heidelberg; University Hospital DresdenNot yet recruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)Germany
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Non-Secretory Plasma Cell Myeloma | PlasmacytosisUnited States
-
Beijing Boren HospitalRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapse LeukemiaChina
-
PETHEMA FoundationAdknoma Health ResearchRecruitingRelapsed Multiple MyelomaSpain
-
Association for Training, Education, and Research...CompletedRelapsed Multiple MyelomaFrance
-
Fortis Therapeutics, Inc.CompletedMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed RemissionUnited States
-
New Epsilon Innovation LimitedActive, not recruitingAdvanced Solid Tumor | Relapsed AML | Refractory AMLHong Kong
-
Arog Pharmaceuticals, Inc.RecruitingRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States, Germany, Spain, Italy, France, Canada
-
Prelude TherapeuticsCompletedAdenoid Cystic Carcinoma | Refractory Chronic Myelomonocytic Leukemia | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory Diffuse Large B-cell Lymphoma | Relapsed/Refractory Advanced Solid Tumors | Relapsed/Refractory Myelodysplasia | Relapsed...United States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Light Chain Deposition DiseaseUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.UnknownMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma ProgressionChina
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Beijing GoBroad HospitalNot yet recruitingRefractory/Relapsed Acute Myeloid LeukaemiaChina
-
Gilead SciencesNo longer availableRelapsed/Refractory Acute Myeloid Leukemia
-
National Research Center for Hematology, RussiaSt. Petersburg State Pavlov Medical University; Federal State Budgetary Institution...RecruitingRefractory Acute Myeloid Leukemia | Early Relapses of Acute Myeloid LeukemiaRussian Federation
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | t(11;14) Negative
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
Oryzon Genomics S.A.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
University Hospital, AntwerpRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryBelgium
-
Medical College of WisconsinRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Peng LiuShanghai East Hospital; Hrain BiotechnologyUnknownMultiple Myeloma in Relapse | Multiple Myeloma ProgressionChina
-
Peking University People's HospitalBeijing JD Biotech Co. LTD.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryChina
-
Xuzhou Medical UniversityRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryChina
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Elucida OncologyTherapeutic Advances in Childhood Leukemia and Lymphoma (TACL)WithdrawnAcute Myeloid Leukemia | AML, Childhood | Relapsed Pediatric AML | Refractory Pediatric AML
-
Hematology department of the 920th hospitalRecruitingRefractory/Relapse Acute Myeloid LeukemiaChina
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Tel-Aviv Sourasky Medical CenterCompletedPlasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Myeloma, Plasma-CellIsrael
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell MyelomaUnited States
-
Xuzhou Medical UniversityRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryChina
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingMyeloid Malignancy | Relapsed/Refractory Acute Myeloid LeukaemiaChina
-
Arog Pharmaceuticals, Inc.CompletedPhase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsRelapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States
-
AmgenMerck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, Canada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States